Fortrea Holdings Inc. FTRE 深 滬
已收盤 02-06 16:00:00 美东时间
14.65
+0.850
+6.16%
華盛通- 最 高14.96
- 今 開14.00
- 成交量 165.16万股
- 最 低 13.87
- 昨 收 13.80
- 總市值 13.54亿
- 52周最高 18.67
- 市盈率 靜 --
- 換手率 1.79%
- 52周最低 3.97
- 委 比 -53.46%
- 總股本 9240.00万
- 歷史最高 41.02
- 量 比 0.87
- 振 幅 7.90%
- 歷史最低 3.97
- 每 手 1
- 風險率 4.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
TD Cowen Maintains Hold on Fortrea Holdings, Raises Price Target to $15
TD Cowen analyst Charles Rhyee maintains Fortrea Holdings (NASDAQ:FTRE) with a Hold and raises the price target from $7 to $15.
01-23 00:47
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Truist Securities Upgrades Fortrea Holdings to Buy, Raises Price Target to $22
Truist Securities analyst Jailendra Singh upgrades Fortrea Holdings (NASDAQ:FTRE) from Hold to Buy and raises the price target from $12 to $22.
01-08 20:38
Fortrea upgraded at Evercore ISI on management changes
Fortrea Holdings (FTRE) traded higher on Tuesday after Evercore ISI upgraded the contract research organization, citing positives in its recent leadership transition, in which a veteran life sciences ...
01-07 02:14
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Citigroup Upgrades Fortrea Holdings to Buy, Raises Price Target to $21
Citigroup analyst Patrick Donnelly upgrades Fortrea Holdings (NASDAQ:FTRE) from Neutral to Buy and raises the price target from $12 to $21.
2025-12-11 22:06
SCTbio And Fortrea Collaborate To Streamline Development, Accelerate Timelines And Bring Advanced Therapies To Patients Faster
SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), today announced a strategic collaboration agreement between
2025-12-04 20:03
